Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines
2018 · Annals of Oncology · 853 citations
https://doi.org/10.1093/annonc/mdy152
R
Raffaele Giusti
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
342
Papers
6.4K
Citations
37
h-index
79
i10-index
Raffaele Giusti is an academic researcher from CTO Andrea Alesini. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Diabetes Treatment and Management & Pancreatic and Hepatic Oncology Research. The author has an h-index of 37, co-authored 291 publications.
ORCID: 0000-0003-4592-8868Papers by this author
worksCOVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
2020 · The Lancet Oncology · 621 citations
https://doi.org/10.1016/s1470-2045(20)30314-4
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable
2019 · Journal for ImmunoTherapy of Cancer · 400 citations
https://doi.org/10.1186/s40425-019-0527-y
2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting
2024 · ESMO Open · 114 citations
https://doi.org/10.1016/j.esmoop.2023.102195
Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation
2020 · Journal for ImmunoTherapy of Cancer · 100 citations
https://doi.org/10.1136/jitc-2020-001403
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours
2023 · Journal of Hepatology · 57 citations
https://doi.org/10.1016/j.jhep.2023.10.040
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat